HCAT
Price
$2.80
Change
-$0.01 (-0.36%)
Updated
Sep 26 closing price
Capitalization
197.05M
45 days until earnings call
OMCL
Price
$30.72
Change
+$0.22 (+0.72%)
Updated
Sep 26 closing price
Capitalization
1.41B
38 days until earnings call
Interact to see
Advertisement

HCAT vs OMCL

Header iconHCAT vs OMCL Comparison
Open Charts HCAT vs OMCLBanner chart's image
Health Catalyst
Price$2.80
Change-$0.01 (-0.36%)
Volume$566.43K
Capitalization197.05M
Omnicell
Price$30.72
Change+$0.22 (+0.72%)
Volume$261.31K
Capitalization1.41B
HCAT vs OMCL Comparison Chart in %
Loading...
HCAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OMCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HCAT vs. OMCL commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCAT is a Hold and OMCL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (HCAT: $2.80 vs. OMCL: $30.73)
Brand notoriety: HCAT and OMCL are both not notable
Both companies represent the Services to the Health Industry industry
Current volume relative to the 65-day Moving Average: HCAT: 38% vs. OMCL: 13%
Market capitalization -- HCAT: $197.75M vs. OMCL: $1.4B
HCAT [@Services to the Health Industry] is valued at $197.75M. OMCL’s [@Services to the Health Industry] market capitalization is $1.4B. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $45.88B to $0. The average market capitalization across the [@Services to the Health Industry] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HCAT’s FA Score shows that 1 FA rating(s) are green whileOMCL’s FA Score has 0 green FA rating(s).

  • HCAT’s FA Score: 1 green, 4 red.
  • OMCL’s FA Score: 0 green, 5 red.
According to our system of comparison, HCAT is a better buy in the long-term than OMCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HCAT’s TA Score shows that 4 TA indicator(s) are bullish while OMCL’s TA Score has 3 bullish TA indicator(s).

  • HCAT’s TA Score: 4 bullish, 4 bearish.
  • OMCL’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, HCAT is a better buy in the short-term than OMCL.

Price Growth

HCAT (@Services to the Health Industry) experienced а -3.29% price change this week, while OMCL (@Services to the Health Industry) price change was -1.95% for the same time period.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was +1.09%. For the same industry, the average monthly price growth was +1.69%, and the average quarterly price growth was +20.02%.

Reported Earning Dates

HCAT is expected to report earnings on Nov 11, 2025.

OMCL is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Services to the Health Industry (+1.09% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OMCL($1.41B) has a higher market cap than HCAT($197M). OMCL YTD gains are higher at: -30.997 vs. HCAT (-60.396). OMCL has higher annual earnings (EBITDA): 103M vs. HCAT (-27.89M). OMCL has more cash in the bank: 412M vs. HCAT (97.3M). HCAT has less debt than OMCL: HCAT (173M) vs OMCL (384M). OMCL has higher revenues than HCAT: OMCL (1.15B) vs HCAT (316M).
HCATOMCLHCAT / OMCL
Capitalization197M1.41B14%
EBITDA-27.89M103M-27%
Gain YTD-60.396-30.997195%
P/E RatioN/A61.44-
Revenue316M1.15B27%
Total Cash97.3M412M24%
Total Debt173M384M45%
FUNDAMENTALS RATINGS
HCAT vs OMCL: Fundamental Ratings
HCAT
OMCL
OUTLOOK RATING
1..100
6866
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
88
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9790
PRICE GROWTH RATING
1..100
9263
P/E GROWTH RATING
1..100
10096
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HCAT's Valuation (26) in the null industry is somewhat better than the same rating for OMCL (88) in the Information Technology Services industry. This means that HCAT’s stock grew somewhat faster than OMCL’s over the last 12 months.

HCAT's Profit vs Risk Rating (100) in the null industry is in the same range as OMCL (100) in the Information Technology Services industry. This means that HCAT’s stock grew similarly to OMCL’s over the last 12 months.

OMCL's SMR Rating (90) in the Information Technology Services industry is in the same range as HCAT (97) in the null industry. This means that OMCL’s stock grew similarly to HCAT’s over the last 12 months.

OMCL's Price Growth Rating (63) in the Information Technology Services industry is in the same range as HCAT (92) in the null industry. This means that OMCL’s stock grew similarly to HCAT’s over the last 12 months.

OMCL's P/E Growth Rating (96) in the Information Technology Services industry is in the same range as HCAT (100) in the null industry. This means that OMCL’s stock grew similarly to HCAT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HCATOMCL
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
60%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
73%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 22 days ago
70%
Bullish Trend 11 days ago
69%
Declines
ODDS (%)
Bearish Trend 10 days ago
82%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
60%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
HCAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OMCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TTDKF14.451.35
+10.32%
TDK Corp.
ARGHF0.34N/A
+0.66%
ARGO CORPORATION
BLBRF0.03N/A
N/A
Bloomberry Resorts Corp
SPFX1.70N/A
N/A
Standard Premium Finance Holdings, Inc.
CZMWF50.00-1.06
-2.08%
Carl Zeiss Meditec AG

HCAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, HCAT has been loosely correlated with KVYO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HCAT jumps, then KVYO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HCAT
1D Price
Change %
HCAT100%
-0.36%
KVYO - HCAT
47%
Loosely correlated
-2.52%
PHR - HCAT
46%
Loosely correlated
+0.72%
EVCM - HCAT
46%
Loosely correlated
-0.52%
CSGS - HCAT
45%
Loosely correlated
+0.42%
RDVT - HCAT
45%
Loosely correlated
+1.22%
More

OMCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OMCL has been loosely correlated with HSTM. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if OMCL jumps, then HSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OMCL
1D Price
Change %
OMCL100%
+0.72%
HSTM - OMCL
38%
Loosely correlated
+0.21%
CWAN - OMCL
38%
Loosely correlated
+0.67%
WEAV - OMCL
36%
Loosely correlated
+1.57%
HCAT - OMCL
33%
Loosely correlated
-0.36%
PHR - OMCL
33%
Poorly correlated
+0.72%
More